Quantcast

Latest Cytomegalovirus Stories

2009-10-07 08:40:00

TUSTIN, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it has established a new Anti-Viral Research Group in its R&D organization. The new group has responsibility for coordinating, expanding and leveraging the company's multiple external collaborations already underway or planned to assess the potential utility of Peregrine's phosphatidylserine (PS)-targeting antibody platform for the prevention and treatment of a...

2009-09-18 08:16:30

Increasing CMV prevention from 3 to 6 months lowers risks while reducing cost For kidney transplant recipients, infection with a virus called cytomegalovirus (CMV) may lead to devastating complications. New research suggests that extending the period of preventive treatment after kidney transplantation can reduce the risk of CMV disease, according to an upcoming report in the Journal of the American Society of Nephrology (JASN). Cytomegalovirus is a common virus that is present in many...

2009-08-31 00:00:00

NUTLEY, N.J., Aug. 31 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease. The FDA also approved a new pediatric oral solution formulation for Valcyte, which will allow easier administration...

2009-08-11 07:00:00

RESEARCH TRIANGLE PARK, N.C., Aug. 11 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, today announced the completion of a $16.1 million Series E financing. Leading life science venture capital investors Canaan Partners, Alta Partners, Sanderling Ventures and Asset Management Company participated in this insider round. Proceeds from the financing will primarily be used to expand Chimerix's clinical development program for its...

2009-06-01 13:15:00

CMV is the most serious viral infection affecting transplant patients BOSTON, June 1 /PRNewswire/ -- New Phase III study results presented for the first time today at the ninth annual American Transplant Congress 2009 (ATC) demonstrate that doubling the duration of preventive therapy ('prophylaxis') with Valcyte (oral valganciclovir) significantly reduced the incidence of CMV disease by 56% in high-risk kidney transplant patients within the first year post-transplant. CMV is a major cause...

2009-05-15 11:02:30

One in three United States adults has high blood pressure, a condition without any known symptoms. A new study suggests that a common virus, cytomegalovirus (CMV), is a cause of high blood pressure and may also lead to hardening in the arteries.Between 60 and 99 percent of adults worldwide are affected by CMV, a virus of the herpes family and the source of congenital infection, mononucleosis and severe infection in transplant patients. Although one may not experience any symptoms, most adults...

2009-03-23 06:55:00

ROCHESTER, N.Y., March 23 /PRNewswire/ -- You went on a diet. Great. You lost weight. Awesome. But what are your chances of keeping the weight off? What are your chances of avoiding the notorious Yo-Yo diet? The Center for the Biology of Chronic Disease recommends that you turn to your doctor and ask for a referral to a simple blood test that measures the concentration of your IgG antibodies against two prevalent viruses, EBV (Epstein-Barr Virus) and CMV (Cytomegalovirus). Look at the...

2009-02-27 10:00:00

A Complimentary Continuing Medical Education Newsletter for Healthcare Professionals VOORHEES, N.J., Feb. 27 /PRNewswire/ -- Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality and is the most common viral opportunistic infection in recipients of solid organ transplant (SOT). Currently, no consensus exists regarding the most appropriate method for preventing CMV, and toxicities and threat of drug resistance occasionally limit the utility of existing antiviral...

2009-02-13 14:30:00

EXTON, Pa., Feb. 13 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that its Phase 3 trial evaluating maribavir used as prophylaxis against cytomegalovirus (CMV) disease in liver transplant patients has been discontinued, and that all patients on study drug are being moved to the current standard of care. The decision was made based on the results of the Phase 3 study of maribavir in stem cell transplant patients, and the recommendation from our independent...

2009-02-09 08:05:00

- Conference Call at 10:00 A.M. Today to Discuss Results - EXTON, Pa., Feb. 9 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint. In the primary analysis, there was no statistically significant difference between maribavir and placebo in reducing the rate of CMV disease. In addition, the...


Latest Cytomegalovirus Reference Libraries

0_bbd337098cfaf28eafeb5f5f010e48ef
2011-01-12 15:30:34

Cytomegalovirus, a herpes viral genus, is known in humans as HCMV. It is part of the Betaherpesvirinae subfamily. Other herpesviruses fall into the subfamilies of Alphaherpesvirinae or Gammaherpesvirinae. xHCMV infections are frequently associated with salivary glands. It can be lethal for people who are immunocompromised. Other CMV viruses are found in several mammal species, but species isolated from animals differ from HCMV in terms of genomic structure. HCMV is found all over the...

More Articles (1 articles) »
Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related